Analyzing Retail REITs: Upgraded Outlook for Tanger, Downgraded Expectations for Kimco and ROIC
BofA Securities analyst Jeffrey Spector upgraded AKR, Tanger Inc., and downgraded KIM and ROIC after Retail Executive Summit with 8 REITs.
FDA Approves Bristol-Myers/2seventy Bio’s Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer
FDA approves Bristol-Myers Squibb and 2seventy Bio Abecma (ide-cel) for relapsed or refractory multiple myeloma after ≥2 prior therapies. Extends progression-free survival by 13.3 months vs. standard care.
Pfizer’s Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study
New England Journal of Medicine publishes Pfizer's Paxlovid trial data, revealing insights into COVID-19 treatment efficacy, hospitalization rates, and adverse events. Learn more about the study's findings and implications.
CVS Health’s Zero-Cost Coverage Paves Way For OTC Birth Control Access
CVS Health expands coverage to include the first OTC birth control pill in the U.S., offering accessible contraception without prescription costs. Learn about this pivotal shift in reproductive healthcare access now.
BASF Lights Up China’s Mega-Project with ENN Energy Gas Deal
BASF signed a contract with ENN Energy for natural gas supply for its Zhanjiang Verbund site in China, boosting clean energy partnership.
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
Corporate bonds offer yield opportunities and diversification away from equity investments. Investment-grade bonds are safer but lower yield, while high-yield bonds offer higher returns but from riskier firms.
Visa Teams Up With Skipify ‘To Enrich Consumer Experiences,’ Shares Rise
Visa (V) shares rise as partnership with Skipify aims to simplify and accelerate payment process, delivering convenience and security for consumers.
New Hope for Aggressive Lung Cancer: AstraZeneca’s Imfinzi Shows Promising Results in Phase 3 Trial
High-level results of AstraZeneca's ADRIATIC Phase 3 trial on Imfinzi monotherapy & Imfinzi plus Imjudo for limited-stage small cell lung cancer. Statistically significant OS & PFS improvement shown vs. placebo.
Top 10 US Corporate Bonds By Market Performance In 2024: April Update
The U.S. corporate bond market had mixed performance in Q1, with higher-rated bonds seeing slight declines and lower-rated bonds showing modest gains. Top performers include Macy's, Ally Financial, and Lincoln National Corp.
UnitedHealth’s Change Healthcare Seeks Consolidation of Cyberattack Lawsuits in Nashville Court
Change Healthcare, a UnitedHealth Group subsidiary, seeks to centralize 24 class actions post-cyber hack. Proposes consolidation aligns with plaintiffs' coalition, emphasizing Tennessee evidence and key witnesses.